Pharmaceutical Technology

JUNE 19, 2025

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 23, 2025

Robert Barrie June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bayer’s Eylea is a heavyweight of the ophthalmic drug landscape, approved for a range of eye diseases. The biosimilar specialist’s stock has been falling over the past year, though the company did post strong Q1 2025 results earlier this year.

Biosimilars 52

Biosimilars Pharmaceutical Manufacturing Communication Hospitals 52

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 24, 2025

June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition will add a suite of products designed for addiction treatment. Finalisation of the transaction hinges on approval during a general meeting scheduled for 14 July 2025, with plans set for completion the following day.

Packaging 52

Packaging Communication Hospitals Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 19, 2025

June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025. The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025.

Communication 52

Communication Hospitals Drug Development Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. Give your business an edge with our leading industry insights. Login Registration is disabled.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Hospitals 52

European Pharmaceutical Review

APRIL 8, 2025

Implementing PAT in (bio)pharmaceutical manufacturing New sensors or larger equipment with more complex setups (software and hardware) require stringent procedures to become fully implemented in a good manufacturing practice (GMP) manufacturing facility.

Documentation 52

Documentation Packaging Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 24, 2025

June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Fluimucil IV is now available to patients across China as an essential hospital-based treatment for respiratory conditions. Give your business an edge with our leading industry insights. Login Registration is disabled.

Hospitals 52

Hospitals Packaging Communication Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 24, 2025

Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

Compounding 52

Compounding Packaging Online Pharmacies Communication 52

Pharmaceutical Technology

JUNE 19, 2025

Robert Barrie June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Both Kisunla and Leqembi are both approved by the Medicines and Healthcare products Regulatory Agency (MHRA), meaning they will still be available privately. Give your business an edge with our leading industry insights.

Communication 59

Communication Hospitals Drug Development Pharmaceutical Manufacturing 59

Pharmaceutical Technology

JUNE 19, 2025

Abigail Beaney June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The ‘space factory’ will likely be within a satellite, King explained at HLTH Europe. In February 2025, Auxilium’s 3D printer built eight implantable medical devices for peripheral nerve repair on the ISS in two hours.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 19, 2025

June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Draig Therapeutics founders: L-R: John Atack, Ruth McKernan and Simon Ward. Credit: Draig Therapeutics/ GlobeNewswire. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 20, 2025

GlobalData Healthcare June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook According to a Novo Nordisk’s speaker at the conference, the company aims to utilise human data input into its target discovery engine. Give your business an edge with our leading industry insights. Login Registration is disabled.

Drug Development 59

Drug Development Pharmaceutical Manufacturing Communication Hospitals 59

Pharmaceutical Technology

JUNE 20, 2025

Robert Barrie June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The positive opinion issued by the EMA’s Committee for Medicinal Products for Human Use (CHMP) signals a strong chance that its drug will be approved. A decision is expected in August 2025. Login Registration is disabled.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Communication Hospitals Packaging 59

Pharmaceutical Commerce

JUNE 18, 2025

Supporting sterile barrier packaging and supply chain resilience The Madison plant reinforces the TekniPlex Healthcare’s goal of assisting pharma and medical companies, which indirectly includes its downstream partners as well. June 12, 2025. Accessed June 18, 2025. Pharmaceutical Commerce. May 6, 2025. Robinson S.

Drug Pricing 52

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Give your business an edge with our leading industry insights. Login Registration is disabled.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In March 2018, Health Canada approved Novartis’ therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer. “We In March 2018, Health Canada approved the therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52

Quality Matters

APRIL 19, 2024

To that end, PEPFAR plans to support the scale-up of regional manufacturing by procuring HIV/AIDS health products from African producers, helping to shape markets and bring investors to the table. But that number will soon change as the number of manufacturers on the continent grows, in part due to PEPFAR and other donors.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Vaccines 52

Pharmaceutical Technology

JUNE 20, 2025

Robert Barrie June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook. The OTP is part of the Center for Biologics Evaluation and Research (CBER) and responsible for reviewing applications cell and gene therapy products. Give your business an edge with our leading industry insights. Login Registration is disabled.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 30, 2025

Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging Drug Pricing Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Drugmakers have poured billions of dollars into pharma manufacturing facilities across the US as they adapt to macroeconomic pressures. Conversely, foreign manufacturing plants will be subject to increased inspection fees.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52